CN102512368A - Production technology of metallothionein flexible nano-liposomes - Google Patents

Production technology of metallothionein flexible nano-liposomes Download PDF

Info

Publication number
CN102512368A
CN102512368A CN2011104188853A CN201110418885A CN102512368A CN 102512368 A CN102512368 A CN 102512368A CN 2011104188853 A CN2011104188853 A CN 2011104188853A CN 201110418885 A CN201110418885 A CN 201110418885A CN 102512368 A CN102512368 A CN 102512368A
Authority
CN
China
Prior art keywords
metallothionein
liposome
production technology
nano
flexible nano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011104188853A
Other languages
Chinese (zh)
Inventor
汪志友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011104188853A priority Critical patent/CN102512368A/en
Publication of CN102512368A publication Critical patent/CN102512368A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a production technology of metallothionein flexible nano-liposomes to people by aiming at the defect that metallothionein and the compound of the metallothionein and other substances (such as common nano-liposomes) are difficult to freely permeate a cell membrane. The production technology comprises the steps of: taking certain amounts of the metallothionein, a protein stabilizer or a freeze-drying protective agent to prepare a buffer solution with a certain concentration; taking certain proportions of phospholipid, chelesterol, surfactant, solvent and the like to prepare an organic phase solution; using a high-pressure pump to fully mix the buffer solution and the organic phase solution for producing a mixed dispersing agent; using an ultrahigh pressure nano homogenizing machine to produce the mixed dispersing agent into nano-liposomes witih more uniform particle sizes; filtering the nano-liposomes through a nano ultrafiltration membrane; and freeze drying and storing. A product which is produced according to the production technology has better storage stability and cell permeability, and can be widely used for making facial cosmetics and preventing and treating cardiocerebral vascular diseases and various diseases.

Description

A kind of production technology of metallothionein flexible nano liposome
Technical field
The present invention relates to a kind of production technology of metallothionein liposome, relate in particular to a kind of production technology of metallothionein flexible nano liposome, belong to field of biological pharmacy.
Background of invention
Metallothionein is one type and is rich in the cysteine group; Various heavy there is high affinity; Under certain PH (pH value) and cellular oxidation-reduction potential environment (but mat organelle somewhere glutathion has reduced form and oxidized form ratio, the demonstration of GSH/GSSG ratio) condition, be prone to and the bonded polypeptide proteins of metal ion such as a plurality of cadmiums, zinc.Mammiferous metallothionein is made up of about 61 aminoacid, contains 20 cysteine and 7 metal ions.Metallothionein has the effective biological functions of multiple uniqueness such as improving body immunity, opposing heavy metal poisoning, storage, transportation and the metabolism of participating in trace element, Plumbum removing zinc supplement, radioprotective, slow down aging, each organ of protection human body cardiopulmonary as a kind of stress protein, free radical resisting oxidant, cell zinc ion mediation agent etc.; Metallothionein is striden the non-memebrane protein macromole of film translation sequence (MTS) and nucleus positioning sequence (NLS) as an acellular film; Use or use or as metallothionein during separately exposed, be difficult to pass freely through cell membrane or nuclear membrane and bring into play its effect with other material complex (like common nanometer liposome) use as the metal ion-chelant metallothionein.Metallothionein is processed the flexible nano liposome, can improve its stability, especially cell membrane permeability: can pass micro channel than the decimal Radix Achyranthis Bidentatae of liposome own.
Summary of the invention
The objective of the invention is; To being the shortcoming that bare metallothionein, metal ion-chelant metallothionein or existing known metal sulfoprotein and other material complex (like common nanometer liposome) all are difficult to pass freely through cell membrane; Biological small duct permeability metallothionein products such as better cell fenestra have been proposed to have, a kind of production technology of metallothionein flexible nano liposome.
Technical scheme of the present invention is achieved in that a kind of production technology of metallothionein flexible nano liposome, realizes that the principal character of the method for this technology comprises the following steps:
1, get metallothionein, protein stabilizing agent or the freeze drying protectant (0.1-5w/v%) in a certain amount of any source, being mixed with concentration is (buffering) aqueous solution of 10-500mM, and the pH value of control solution is between 6.5 to 9.0.
2, get a certain proportion of phospholipid (0.5-10w/v%), cholesterol (0.5-10w/v%), surfactant (0.5-10w/v%), solvent (5-95v/v%) etc. and process organic facies liquid;
3, above buffer and organic phase solution are imported high-pressure pump, fully be mixed and made into mixed dispersion liquid under the condition of nitrogen protection comprising;
4, with above mixed dispersion liquid 4~80 ℃ of homogenizing operating pressure 5-480MPa, homogenizing operating temperatures, comprise under the condition of nitrogen protection and to process nano dispersion fluid through supertension nanometer homogenizer;
5, be the ultrafilter membrane of 100-200nm with above nano dispersion fluid through the aperture, comprise under the nitrogen protection condition and filtering, process metallothionein flexible nano liposome;
6, with above metallothionein flexible nano liposome through lyophilization, bottling, inflated with nitrogen, seal, in 4~20 ℃ of preservations.
Theoretical foundation of the present invention is:
The surfactant molecule of embedding metallothionein flexible nano liposome coating layer can be accumulated at the high pressure position and produce deformation, forms bigger high curvature structure; This structure can reduce the energy dissipation in nanoparticle formation and the storage process; Thereby make the flexible nano liposome have the shape variable property of height; Make it the penetrating aperture micro channel littler 5 times efficiently than itself particle diameter; And common nanometer liposome then can not pass through when its particle diameter is 1.7 times of micro channel fully.The flexible nano liposome has also been given hydrophilic, permeability and the stability of liposome height, thereby has overcome metallothionein owing to lack many obstacles of sending to cyton, organelle, organism of striding that film translation sequence (MTS) and nucleus positioning sequence (NLS) cause.
Effect effect of the present invention is:
1, through using a series of modern nanometer pharmaceutical production technology such as high-pressure pump mixing, the pelletize of supertension nanometer homogenizer, ultrafiltration membrance filter, the quality of strict control nanometer liposome is prepared more even, the controlled nanometer liposome of particle size distribution;
2, through above-mentioned preparation technology, select rational lipid, surfactant, protein stabilization protective agent prescription for use, obtain high performance flexible nano liposome;
3, through nitrogen protection, flexible nano liposome preparation technology, improved the stability of liposome, comprise storage stability;
4, through above-mentioned preparation technology; Prepared nanometer liposome particle size distribution is 30-300nm, be typically 80-120nm; Mean diameter is 80-200nm, be typically 100nm; Encapsulation ratio is 50-99%, is typically 80-90% that the stable storing phase is 4-12 month, is typically 6-8 month;
5, the flexible nano liposome through making makes metallothionein see through micro channel on the little cyton to 10-30nm in aperture, organelle, the organism etc. efficiently.
The specific embodiment
Embodiment one: the purity that 100mg is extracted by Hepar Leporis seu Oryctolagi is 99% metallothionein, 1.5g sodium alginate, 100mg glutathion; Being dissolved in the pH value that 100ml is made into by injection stage water is that 6.8 concentration are in the 100mM phosphate PBS buffer solution; Mix homogeneously; Remove by filter insoluble matter, place 5 ℃ of ice baths or refrigerator; Get 3g lecithin, 100mg cholesterol, 200mg sodium cholate, 200mg DSPC, be dissolved in the mixed solvent of being made up of 25ml water and 75ml dehydrated alcohol, mix homogeneously removes by filter insoluble matter, places 5 ℃ of ice baths or refrigerator.
Above buffer and organic phase solution are imported in the high-pressure pump,, process mixed dispersion liquid fully mixing 5 minutes less than under 15 ℃, the condition of nitrogen protection.
Above mixed dispersion liquid is imported homogenizing operating pressure feeder, open nitrogen protection, under 150MPa15 ℃ of condition,, process nano dispersion fluid through supertension nanometer homogenizer.
Is the ultrafilter membrane of 100nm with above nano dispersion fluid through the aperture, under the nitrogen protection condition, filters, and processes metallothionein flexible nano liposome, and its particle size distribution is that 60-120nm, envelop rate are 91%.
With above metallothionein flexible nano liposome through lyophilization, bottling, inflated with nitrogen, seal, in 4 ℃ of preservations.
Embodiment two: the purity that 150mg is extracted by Hepar Leporis seu Oryctolagi is 99% metallothionein, 2.0g mannitol, 200mg glucosan; Being dissolved in the pH value that 100ml is made into by injection stage water is that 6.8 concentration are in the 100mMTris-HCl buffer solution; Mix homogeneously; Remove by filter insoluble matter, place 5 ℃ of ice baths or refrigerator; Get 5g lecithin, 150mg cholesterol, 250mg sodium cholate, 200mg Polysorbate, 250mg DSPC; Be dissolved in the mixed solvent of forming by 20ml water and 100ml dehydrated alcohol; Mix homogeneously removes by filter insoluble matter, places 5 ℃ of ice baths or refrigerator.
Above buffer and organic phase solution are imported in the high-pressure pump,, process mixed dispersion liquid fully mixing 5 minutes less than under 15 ℃, the condition of nitrogen protection.
Above mixed dispersion liquid is imported homogenizing operating pressure feeder, open nitrogen protection, under 150MPa15 ℃ of condition,, process nano dispersion fluid through supertension nanometer homogenizer.
Is the ultrafilter membrane of 100nm with above nano dispersion fluid through the aperture, under the nitrogen protection condition, filters, and processes metallothionein flexible nano liposome, and its particle size distribution is that 75-120nm, envelop rate are 87%.
With above metallothionein flexible nano liposome through lyophilization, bottling, inflated with nitrogen, seal, in 4 ℃ of preservations.

Claims (8)

1. the production technology of a metallothionein flexible nano liposome, its characteristic comprises the following steps:
A, get a certain amount of metallothionein, protein stabilizing agent or freeze drying protectant, be mixed with certain density buffer solution.
B, get a certain proportion of phospholipid, cholesterol, surfactant, protein stabilizing agent or freeze drying protectant, solvent etc. and process organic phase solution.
C, above buffer and organic phase solution fully are mixed and made into mixed dispersion liquid through high-pressure pump.
D, mixed dispersion liquid is processed the more equally distributed nanometer liposome of particle diameter through supertension nanometer homogenizer.
E, with nanometer liposome through the nanometer ultrafiltration membrance filter.
F, lyophilization, preservation.
2. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that:
The said metallothionein of steps A comprises natural extract, synthetic, all metallothioneins genetic engineering-dna recombinant expression, people-animal-plant-microorganism source; Said protein stabilizing agent or freeze drying protectant are one or more of sucrose, trehalose, mannitol, glutathion, lactose, glucose, maltose, glucosan, albumin, L-serine, sodium glutamate, alanine, glycine, sarcosine, phosphate, acetate, citrate, taurine, chitosan, oligochitosan etc.; Said concentration is 10-500mM; Said solution comprises deionized water, sterile deionized water, water for injection, PBS or similar solution such as other phosphate buffer, Tris-HCl buffer.
3. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that:
The said phospholipid of step B is phosphatidylcholine (lecithin; PC), PHOSPHATIDYL ETHANOLAMINE (cephalin; PE), Phosphatidylserine (PS), one or more of phosphatidylinositols (PI), phosphatidyl glycerol (PG), diphosphatidylglycerol phosphoglycerides (containing modified glycerol phospholipid, phosphoglyceride derivant such as DSPC DSPC) such as (cuorins); Said surfactant is that sodium cholate, cholic acid potassium, sodium deoxycholate, deoxycholic acid potassium, fatty acid Pyrusussuriensis are smooth, Polysorbate, sucrose ester, dioctyl sodium sulfosuccinate, sodium laurate etc. one or more; Said solvent be ethanol, water equal solvent etc. one or more.
4. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that:
The condition of step C is mixing temperature-5-30 ℃, incorporation time 30 seconds to 30 minutes, comprises nitrogen protection.
5. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that:
The said supertension nanometer of step D homogenizer homogenizing operating pressure is that 5-480MPa, homogenizing operating temperature are 4~80 ℃, comprises nitrogen protection; The system of processing through this step is called nano dispersion fluid.
6. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that:
The said ultrafilter membrane of step e aperture is 100-200nm, and filter process comprises nitrogen protection, and the system of processing through this step is called the flexible nano liposome.
7. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that:
Steps A-E comprises storage tank, the liquid inventory metering valve of solution, and the automatic control system that is made up of storage tank, valve, high-pressure pump, supertension nanometer homogenizer, production process mass detecting instrument instruments and meters etc.
8. according to the production technology of the said metallothionein flexible nano of claim 1 liposome, it is characterized in that: the metallothionein flexible nano liposome particle size distribution that makes is that 30-400nm, mean diameter are that 80-200nm, encapsulation ratio are 50-99%, stable storing phase to be 4-12 month.
CN2011104188853A 2011-12-15 2011-12-15 Production technology of metallothionein flexible nano-liposomes Pending CN102512368A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104188853A CN102512368A (en) 2011-12-15 2011-12-15 Production technology of metallothionein flexible nano-liposomes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104188853A CN102512368A (en) 2011-12-15 2011-12-15 Production technology of metallothionein flexible nano-liposomes

Publications (1)

Publication Number Publication Date
CN102512368A true CN102512368A (en) 2012-06-27

Family

ID=46283630

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104188853A Pending CN102512368A (en) 2011-12-15 2011-12-15 Production technology of metallothionein flexible nano-liposomes

Country Status (1)

Country Link
CN (1) CN102512368A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434504A (en) * 2014-08-29 2016-03-30 四川科伦药业股份有限公司 Fat emulsion tail liquid treatment apparatus and method thereof
CN109295182A (en) * 2018-09-30 2019-02-01 苏州百源基因技术有限公司 A kind of PCR dispenses the reaction tube of reagent and prepackage PCR reagent in advance
CN110464836A (en) * 2018-05-11 2019-11-19 中国医学科学院药物研究所 A kind of insulin flexibility microparticle compositions
CN111034807A (en) * 2019-12-18 2020-04-21 安徽农业大学 Method for preparing α -albumin-rich cheese by adopting ultrahigh pressure auxiliary tangential membrane filtration
CN111621585A (en) * 2020-04-16 2020-09-04 大连民族大学 Rapid detection kit for simultaneously detecting multiple transgenic rape lines and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1957924A (en) * 2006-11-22 2007-05-09 上海微纳科技有限公司 Nano liposome of tea plant oil, and preparation method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1957924A (en) * 2006-11-22 2007-05-09 上海微纳科技有限公司 Nano liposome of tea plant oil, and preparation method

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
《中国新药杂志》 20061231 王弘等 新型透皮给药载体--传递体研究进展 第341-344页 1-8 第15卷, 第5期 *
A.PAUL,ET AL: "lkansdermal immunisation with an integral membrane component,gap junction protein,by means of ultradeformable drug carriers,transfersomes", 《VACCINE》 *
G.CEÍC ET AL: "Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin", 《BIOCHIMICA ET BIOPHYSICA ACTA》 *
G.CEVC ET AL: "Transdermal drug carriers: basic properties,optimization and transfer efficiency in the case of epicutaneously applied peptides", 《JOURNAL OF CONTROLLED RELEASE》 *
王弘等: "新型透皮给药载体——传递体研究进展", 《中国新药杂志》 *
谢悦良等: "柔性纳米脂质体的研究进展", 《中国药房》 *
陈国广等: "肝素透皮吸收传递体的研制", 《中国药科大学学报》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434504A (en) * 2014-08-29 2016-03-30 四川科伦药业股份有限公司 Fat emulsion tail liquid treatment apparatus and method thereof
CN110464836A (en) * 2018-05-11 2019-11-19 中国医学科学院药物研究所 A kind of insulin flexibility microparticle compositions
CN109295182A (en) * 2018-09-30 2019-02-01 苏州百源基因技术有限公司 A kind of PCR dispenses the reaction tube of reagent and prepackage PCR reagent in advance
CN111034807A (en) * 2019-12-18 2020-04-21 安徽农业大学 Method for preparing α -albumin-rich cheese by adopting ultrahigh pressure auxiliary tangential membrane filtration
CN111621585A (en) * 2020-04-16 2020-09-04 大连民族大学 Rapid detection kit for simultaneously detecting multiple transgenic rape lines and application thereof

Similar Documents

Publication Publication Date Title
CN102512368A (en) Production technology of metallothionein flexible nano-liposomes
CN102274183B (en) Preparation method and application of multi-vesicular liposome
CN103040748B (en) Pemetrexed disodium liposome injection
CN111053757A (en) Lipid nanoparticles targeting hepatic stellate cells, preparation method and application thereof
CN102218031A (en) Formula, preparation method and use of lactose-azithromycin liposome combined medicine
CN101891809A (en) Preparation and application of phycocyanin extract
Claro et al. Macromolecular assembly and membrane activity of antimicrobial D, L-α-Cyclic peptides
Ma et al. Crosslinked zwitterionic microcapsules to overcome gastrointestinal barriers for oral insulin delivery
JPH05194191A (en) Liposome pharmaceutical preparation
CN105943502A (en) Lipidosome medicine carrying method
KR102009240B1 (en) Chitosan-pluronic complex composite and nanocarrier comprising the same
CN103040756B (en) A kind of preparation method of mPEG epirubicin hydrochloride magnetic liposome
CN115192545B (en) Multilayered multiphase nanoparticle
CN102552149B (en) Calcium heparin liposome preparation for injection
EP1227794A2 (en) Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use
CN109078001B (en) Vancomycin nanoliposome composition and preparation method thereof
KR101837023B1 (en) Cosmetic nanoliposome composition containg peptides for inhibiting degradation of collagen and manufacturing method thereof
WO2021041784A1 (en) Hemoglobin-based nanoparticles for oxygen delivery
CN102335134B (en) Clevidipine butyrate liquid liposome preparation
KR101687735B1 (en) Method for production of liposome powder with novel freeze drying supplement and novel solvent for phosphlipid
RU2717824C2 (en) METHOD OF PRODUCING VESICLES WITH TRANSMEMBRANE GRADIENT pH
CN103585119A (en) Stabilization preparation containing epoprostenol and medical salt of epoprostenol and preparation method of stabilization preparation
CN104490800B (en) A kind of good fortune department Fluconazole freezes compound powder and preparation method thereof
CN103040723B (en) Xiyanping lipidosome injection
EP4062940A1 (en) Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: 213161, Room 102, unit 57, Hutang four seasons new town, Wujin District, Jiangsu, Changzhou

Applicant after: Wang Zhiyou

Address before: 100093 Beijing city Haidian District minzhuang Road Beijing Fragrant Garden No. 80

Applicant before: Wang Zhiyou

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM:

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: Room 158, biological building, No. 217, Renmin East Road, Wujin District, Changzhou, Hutang, 213161, Jiangsu

Applicant after: Wang Zhiyou

Address before: 213161, Room 102, unit 57, Hutang four seasons new town, Wujin District, Jiangsu, Changzhou

Applicant before: Wang Zhiyou

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120627